The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: inhibition of AP1 binding and activation of a silencer element - PubMed (original) (raw)
Comparative Study
The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: inhibition of AP1 binding and activation of a silencer element
J Ye et al. Mol Cell Biol. 1996 Sep.
Abstract
Our group has previously reported that the nuclear factor Yin-Yang 1 (YY1), a ubiquitous DNA-binding protein, is able to interact with a silencer element (BE) in the gamma interferon (IFN-gamma) promoter region. In this study, we demonstrated that YY1 can directly inhibit the activity of the IFN-gamma promoter by interacting with multiple sites in the promoter. In cotransfection assays, a YY1 expression vector significantly inhibited IFN-gamma promoter activity. Mutation of the YY1 binding site in the native IFN-gamma promoter was associated with an increase in the IFN-gamma promoter activity. Analysis of the DNA sequences of the IFN-gamma promoter revealed a second functional YY1 binding site (BED) that overlaps with an AP1 binding site. In this element, AP1 enhancer activity was suppressed by YY1. Since the nuclear level of YY1 does not change upon cell activation, our data support a model that the nuclear factor YY1 acts to suppress basal IFN-gamma transcription by interacting with the promoter at multiple DNA binding sites. This repression can occur through two mechanisms: (i) cooperation with an as-yet-unidentified AP2-like repressor protein and (ii) competition for DNA binding with the transactivating factor AP1.
Similar articles
- Characterization of a silencer regulatory element in the human interferon-gamma promoter.
Ye J, Ghosh P, Cippitelli M, Subleski J, Hardy KJ, Ortaldo JR, Young HA. Ye J, et al. J Biol Chem. 1994 Oct 14;269(41):25728-34. J Biol Chem. 1994. PMID: 7929277 - Hormonal regulation of transcription factor activity in mammary epithelial cells.
Groner B, Altiok S, Meier V. Groner B, et al. Mol Cell Endocrinol. 1994 Apr;100(1-2):109-14. doi: 10.1016/0303-7207(94)90288-7. Mol Cell Endocrinol. 1994. PMID: 8056143 Review. - Transcription factor YY1: structure, function, and therapeutic implications in cancer biology.
Gordon S, Akopyan G, Garban H, Bonavida B. Gordon S, et al. Oncogene. 2006 Feb 23;25(8):1125-42. doi: 10.1038/sj.onc.1209080. Oncogene. 2006. PMID: 16314846 Review.
Cited by
- Regulation of PD-L1 Expression by YY1 in Cancer: Therapeutic Efficacy of Targeting YY1.
Dillen A, Bui I, Jung M, Agioti S, Zaravinos A, Bonavida B. Dillen A, et al. Cancers (Basel). 2024 Mar 21;16(6):1237. doi: 10.3390/cancers16061237. Cancers (Basel). 2024. PMID: 38539569 Free PMC article. Review. - IFN-γ and TGF-β, Crucial Players in Immune Responses: A Tribute to Howard Young.
Gauthier T, Chen W. Gauthier T, et al. J Interferon Cytokine Res. 2022 Dec;42(12):643-654. doi: 10.1089/jir.2022.0132. J Interferon Cytokine Res. 2022. PMID: 36516375 Free PMC article. Review. - Identification of non-coding silencer elements and their regulation of gene expression.
Pang B, van Weerd JH, Hamoen FL, Snyder MP. Pang B, et al. Nat Rev Mol Cell Biol. 2023 Jun;24(6):383-395. doi: 10.1038/s41580-022-00549-9. Epub 2022 Nov 7. Nat Rev Mol Cell Biol. 2023. PMID: 36344659 Review. - YY1 Upregulates Checkpoint Receptors and Downregulates Type I Cytokines in Exhausted, Chronically Stimulated Human T Cells.
Balkhi MY, Wittmann G, Xiong F, Junghans RP. Balkhi MY, et al. iScience. 2018 Apr 27;2:105-122. doi: 10.1016/j.isci.2018.03.009. Epub 2018 Apr 11. iScience. 2018. PMID: 30428369 Free PMC article.
References
- Cell. 1986 May 23;45(4):601-10 - PubMed
- Proc Natl Acad Sci U S A. 1990 Jul;87(13):5046-50 - PubMed
- Cell. 1987 Sep 25;50(7):1057-69 - PubMed
- Cell. 1991 Oct 18;67(2):377-88 - PubMed
- Mol Cell Biol. 1992 Sep;12(9):4209-14 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials